Merrimack Pharmaceuticals
MACK
#7786
Rank
NZ$0.37 B
Marketcap
$25.31
Share price
0.00%
Change (1 day)
20.17%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Net assets

Net assets on the balance sheet as of March 2024 : NZ$0.37 Billion

According to Merrimack Pharmaceuticals's latest financial reports the company has NZ$0.37 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Merrimack Pharmaceuticals - Net assets on balance sheet (from 2010 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$29.64 M-2.21%
2022-12-31$NZ$30.31 M45.95%
2021-12-31$NZ$20.77 M-6.37%
2020-12-31$NZ$22.18 M-13.7%
2019-12-31$NZ$25.7 M-70.69%
2018-12-31$NZ$87.68 M-35.32%
2017-12-31$NZ$0.13 B-137.17%
2016-12-31$-NZ$0.37 Billion35.9%
2015-12-31$-NZ$0.27 Billion106.02%
2014-12-31$-NZ$0.14 Billion148.22%
2013-12-31$-NZ$52.49 Million572.49%
2012-12-31$-NZ$7.81 Million-71.92%
2011-12-31$-NZ$27.8 Million-90.21%
2010-12-31$-NZ$0.29 Billion8.05%
2009-12-31$-NZ$0.27 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$130.90 B 35,204.13%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$48.25 M-86.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.51 B 38.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.7 Billion-288.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.27 Million-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA